Clinical Trials Logo

Healthy Chinese Volunteers clinical trials

View clinical trials related to Healthy Chinese Volunteers.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04495322 Completed - Clinical trials for Healthy Chinese Volunteers

To Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of TG-1000 in Healthy Volunteers, and the Food Effect on Pharmacokinetics of Single Oral Dose of TG-1000 in Healthy Volunteers.

Start date: July 17, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics profiles of TG-1000 in healthy volunteers, and to evaluate the food effect on pharmacokinetics of single oral dose of TG-1000 in healthy volunteers.

NCT ID: NCT03971916 Completed - Clinical trials for Healthy Chinese Volunteers

A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

Start date: June 3, 2019
Phase: Phase 1
Study type: Interventional

Trial Objective: To investigate the safety, tolerability, PK, and PD following single ascending doses of HBM9161 in healthy Chinese subjects.

NCT ID: NCT03610880 Completed - Clinical trials for Healthy Chinese Volunteers

To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers

Start date: October 17, 2017
Phase: Phase 1
Study type: Interventional

To evaluate the drug-drug reactions between TG-2349 and DAG181, and the pharmacokinetics and tolerability profile in healthy Chinese volunteers to be the reference for protocol designs of subsequent clinical trials.

NCT ID: NCT03610867 Completed - Clinical trials for Healthy Chinese Volunteers

To Evaluate the Safety, Tolerability, and Pharmacokinetics Profile in Healthy Chinese Volunteers of TG-2349

Start date: April 27, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) profile of different doses of TG-2349 (Furaprevir capsule) in healthy Chinese volunteers.

NCT ID: NCT01720212 Completed - Clinical trials for Healthy Chinese Volunteers

Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers

Start date: May 2012
Phase: Phase 1
Study type: Interventional

To evaluate the safety and plasma concentration change of YM178 after single- and repeated-administration as oral absorption controlled tablet in healthy Chinese subjects.